Dysfunctional Innate Immune Responses and Severe Dengue

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• Dengue virus (DENV) infection typically causes mild illness, but severe dengue develops in some individuals.
• Emerging evidence suggests that an aberrant immune response during early infection contributes to severe dengue.
• Elevated inflammatory mediators and immune cell dysregulation are observed in severe dengue cases.

Purpose of the Study:

• To review and compare innate immune responses in patients with severe dengue versus mild dengue.
• To elucidate the mechanisms driving severe dengue pathogenesis.
• To identify potential therapeutic targets for dengue treatment.

Main Methods:

• Review of existing literature on dengue virus infection and immune responses.
• Analysis of inflammatory cytokines, chemokines, and lipid mediators in dengue patients.
• Examination of immune cell function (monocytes, mast cells) during DENV infection.

Main Results:

• Severe dengue is associated with higher levels of inflammatory cytokines, chemokines, and lipid mediators.
• DENV infection, particularly with suboptimal antibodies, triggers pro-inflammatory cytokine production and inhibits interferon signaling.
• Immunosuppressive cytokines (e.g., IL-10) and altered innate immune cell phenotypes contribute to disease severity.

Conclusions:

• Dysregulated innate immune responses, including excessive inflammation and impaired antiviral activity, lead to severe dengue.
• Comorbidities may exacerbate severe dengue by altering innate immunity and gut microbiota.
• Further characterization of these immune mechanisms is crucial for developing effective dengue therapies.